**美股 ACMB 發布全球首創「股幣合一」模式台灣躍升 AI × 生技 × 新金融的國際標準制定者**
台北–香港–紐約｜2025 年 11 月 17 日
全球 AI 市值於 2025 年正式突破 11 兆美元，成為全球資本市場最強勁的驅動力量。NVIDIA 執行長黃仁勳日前再次強調：「沒有台積電，就沒有輝達。」這句話不僅凸顯台灣在 AI 供應鏈的核心地位，也象徵一場新的全球投資浪潮正由台灣向世界擴散—--AI × 植物新藥 × 新金融（Tokenized Equity） 三軸革命正式成形。
台灣成為全球唯一 AI × 生技 × 半導體三強匯聚的創新中心憑藉 25 年累積的植物新藥研發與全球最先進的半導體算力，台灣已成為世界最具整合性的 AI 生技創新基地。關鍵優勢包括：
ACMB 成為全球 AI × 生技 × Tokenized Equity 的關鍵樞紐美股 ACMB（OTC） 已建構完整的 AI 生技知識資產核心，包括：
全球首創：ACMB 發布 SEC 可接受的「股幣合一」Tokenized Equity 標準ACMB 宣布推出全球第一個 股權＝代幣＝同價、同權、同源 的 Tokenized Equity 架構。其市場意義包括：
全球專家齊聚三地：ACMB 站上新金融國際舞台核心ACMB 今日於台北–香港–紐約同步舉辦
「全球 AI × Tokenized Equity 高峰論壇」
邀集超過 30 位來自 AI、生技、Web3、資本市場與監理機構的國際專家，參與城市包括台北、香港、新加坡、倫敦和紐約。
論壇共識指出：
Tokenized Equity 將在 2026–2030 年間成為全球募資與證券市場的核心架構。
ACMB 也同步宣布啟動 2025–2027 年十輪全球股幣合一增發計畫，以最透明、可追溯方式向全球投資人開放。
結語：台灣邁向全球新金融規則制定者當全球 AI 生態系依賴台灣的算力時，ACMB 展現另一個不可忽視的事實：
沒有台灣，也不會有下一代 AI × 生技 × 新金融的國際標準。
ACMB 正站在全球制度創新的第一線，也成為國際資本市場關注的跨領域投資新焦點。
台北–香港–紐約｜2025 年 11 月 17 日
全球 AI 市值於 2025 年正式突破 11 兆美元，成為全球資本市場最強勁的驅動力量。NVIDIA 執行長黃仁勳日前再次強調：「沒有台積電，就沒有輝達。」這句話不僅凸顯台灣在 AI 供應鏈的核心地位，也象徵一場新的全球投資浪潮正由台灣向世界擴散—--AI × 植物新藥 × 新金融（Tokenized Equity） 三軸革命正式成形。
台灣成為全球唯一 AI × 生技 × 半導體三強匯聚的創新中心憑藉 25 年累積的植物新藥研發與全球最先進的半導體算力，台灣已成為世界最具整合性的 AI 生技創新基地。關鍵優勢包括：
- 全球 70% AI 製造鏈集中於台灣
- 全球最成熟的牛樟芝（Antrodia）植物新藥研發環境
- AI 在毒理預測、免疫建模、生成式分子模擬的全面應用
- 與美國 OTC 市場資訊披露、合規與植物藥監理機制高度接軌
ACMB 成為全球 AI × 生技 × Tokenized Equity 的關鍵樞紐美股 ACMB（OTC） 已建構完整的 AI 生技知識資產核心，包括：
- 13 項植物新藥專利
- 標準化製程與多靶點複方模型
- AI 毒理與免疫調控資料庫
- 完全符合美國 OTC 規範的資訊透明結構
全球首創：ACMB 發布 SEC 可接受的「股幣合一」Tokenized Equity 標準ACMB 宣布推出全球第一個 股權＝代幣＝同價、同權、同源 的 Tokenized Equity 架構。其市場意義包括：
- 代幣直接代表真實股權，而非點數或平台憑證
- 全程可追溯、透明、跨境可流通
- 傳統股權第一次獲得 Web3 級別的全球流動性
- 具備被全球企業複製並形成通用標準的潛力
全球專家齊聚三地：ACMB 站上新金融國際舞台核心ACMB 今日於台北–香港–紐約同步舉辦
「全球 AI × Tokenized Equity 高峰論壇」
邀集超過 30 位來自 AI、生技、Web3、資本市場與監理機構的國際專家，參與城市包括台北、香港、新加坡、倫敦和紐約。
論壇共識指出：
Tokenized Equity 將在 2026–2030 年間成為全球募資與證券市場的核心架構。
ACMB 也同步宣布啟動 2025–2027 年十輪全球股幣合一增發計畫，以最透明、可追溯方式向全球投資人開放。
結語：台灣邁向全球新金融規則制定者當全球 AI 生態系依賴台灣的算力時，ACMB 展現另一個不可忽視的事實：
沒有台灣，也不會有下一代 AI × 生技 × 新金融的國際標準。
ACMB 正站在全球制度創新的第一線，也成為國際資本市場關注的跨領域投資新焦點。
|
|
📌【English Version｜Press Release】**US OTC-Listed ACMB Unveils the World’s First “Equity–Token Unification” ModelTaiwan Emerges as the Global Standard Setter for AI × Biotech × New Finance**
TAIPEI–HONG KONG–NEW YORK｜November 17, 2025
The global AI industry surpassed USD 11 trillion in market value in 2025, becoming the dominant force reshaping global capital markets. NVIDIA CEO Jensen Huang recently reiterated, “Without TSMC, there is no NVIDIA.”
His remarks underscore Taiwan’s pivotal role in the AI supply chain and signal the rise of a new investment paradigm originating from Taiwan:
AI × Botanical New Drugs × Tokenized Equity.
Taiwan: The Only Market Where AI, Biotech, and Semiconductor Power ConvergeWith 25 years of botanical drug R&D and the world’s most advanced semiconductor computing capabilities, Taiwan has become the most comprehensive innovation hub for AI-driven biotech. Key strengths include:
ACMB Emerges as a Global Nexus for AI × Biotech × Tokenized EquityU.S. OTC-listed ACMB has established an integrated knowledge and intellectual property base, including:
A Global First: ACMB Introduces an SEC-Acceptable “Equity–Token Unification” StandardACMB announced the world’s first Tokenized Equity structure in which equity = token = identical price, identical rights, identical origin. Key implications include:
Global Experts Convene Across Three CitiesACMB today hosted the
Global AI × Tokenized Equity Summit,
connecting more than 30 experts across AI, biotech, Web3, investment, and regulatory sectors from Taipei, Hong Kong, Singapore, London, and New York.
Consensus from the summit:
Tokenized Equity will become a core architecture of global fundraising and securities markets from 2026 to 2030.
ACMB also announced the launch of its 2025–2027 ten-round global issuance plan under the unified equity–token structure.
Conclusion: Taiwan Advances from AI Manufacturer to AI Financial Rule MakerAs the world relies on Taiwan’s semiconductor power for next-generation AI, ACMB underscores another truth:
Without Taiwan, there will be no next global standard for AI × biotech × new finance.
ACMB now stands at the forefront of a global financial and technological transformation, presenting a new class of international investment opportunities.
TAIPEI–HONG KONG–NEW YORK｜November 17, 2025
The global AI industry surpassed USD 11 trillion in market value in 2025, becoming the dominant force reshaping global capital markets. NVIDIA CEO Jensen Huang recently reiterated, “Without TSMC, there is no NVIDIA.”
His remarks underscore Taiwan’s pivotal role in the AI supply chain and signal the rise of a new investment paradigm originating from Taiwan:
AI × Botanical New Drugs × Tokenized Equity.
Taiwan: The Only Market Where AI, Biotech, and Semiconductor Power ConvergeWith 25 years of botanical drug R&D and the world’s most advanced semiconductor computing capabilities, Taiwan has become the most comprehensive innovation hub for AI-driven biotech. Key strengths include:
- 70% of the global AI hardware supply chain located in Taiwan
- The world’s most mature R&D ecosystem for Antrodia-based botanical drugs
- Advanced AI applications in toxicology prediction, immune modeling, and generative molecular simulation
- Strong regulatory alignment with the U.S. OTC market
ACMB Emerges as a Global Nexus for AI × Biotech × Tokenized EquityU.S. OTC-listed ACMB has established an integrated knowledge and intellectual property base, including:
- 13 botanical new drug patents
- Standardized multi-target formulation platforms
- AI-driven toxicology and immune-regulation datasets
- A fully U.S. OTC-compliant disclosure framework
A Global First: ACMB Introduces an SEC-Acceptable “Equity–Token Unification” StandardACMB announced the world’s first Tokenized Equity structure in which equity = token = identical price, identical rights, identical origin. Key implications include:
- Tokens represent real equity—not points, credits, or utility tokens
- Fully traceable, transparent, and globally transferable
- Traditional equity gains Web3-level liquidity for the first time
- Potential to become a replicable international standard for global enterprises
Global Experts Convene Across Three CitiesACMB today hosted the
Global AI × Tokenized Equity Summit,
connecting more than 30 experts across AI, biotech, Web3, investment, and regulatory sectors from Taipei, Hong Kong, Singapore, London, and New York.
Consensus from the summit:
Tokenized Equity will become a core architecture of global fundraising and securities markets from 2026 to 2030.
ACMB also announced the launch of its 2025–2027 ten-round global issuance plan under the unified equity–token structure.
Conclusion: Taiwan Advances from AI Manufacturer to AI Financial Rule MakerAs the world relies on Taiwan’s semiconductor power for next-generation AI, ACMB underscores another truth:
Without Taiwan, there will be no next global standard for AI × biotech × new finance.
ACMB now stands at the forefront of a global financial and technological transformation, presenting a new class of international investment opportunities.
